Intrafractional and Interfractional Range Variation in Charged Particle Therapy of Lung Cancer

Reviewer: Geoffrey Geiger MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 14 de octubre del 2009

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

More Evidence Needed on Charged-Particle Therapy

Nov 25, 2015

Research scarce on comparative effectiveness, safety of charged-particle therapy for cancer

Genetic Variation Impacts Aspirin/NSAID Link to CRC Risk

Mar 18, 2015

Use of aspirin, NSAIDs lowers risk of CRC in association with genetic variation at two SNPs

International Variation in Lung Cancer Trends Seen in Women

May 28, 2014

Lung cancer mortality stable or declining for young women; increasing for older women